Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum

Swansea University, UK.
BMC Cancer (Impact Factor: 3.36). 11/2010; 10(1):640. DOI: 10.1186/1471-2407-10-640
Source: PubMed


Survival time for lung cancer is poor with over 90% of patients dying within five years of diagnosis primarily due to detection at late stage. The main objective of this study was to evaluate Fourier transform infrared spectroscopy (FTIR) as a high throughput and cost effective method for identifying biochemical changes in sputum as biomarkers for detection of lung cancer.
Sputum was collected from 25 lung cancer patients in the Medlung observational study and 25 healthy controls. FTIR spectra were generated from sputum cell pellets using infrared wavenumbers within the 1800 to 950 cm-1 "fingerprint" region.
A panel of 92 infrared wavenumbers had absorbances significantly different between cancer and normal sputum spectra and were associated with putative changes in protein, nucleic acid and glycogen levels in tumours. Five prominent significant wavenumbers at 964 cm-1, 1024 cm-1, 1411 cm-1, 1577 cm-1 and 1656 cm-1 separated cancer spectra from normal spectra into two distinct groups using multivariate analysis (group 1: 100% cancer cases; group 2: 92% normal cases). Principal components analysis revealed that these wavenumbers were also able to distinguish lung cancer patients who had previously been diagnosed with breast cancer. No patterns of spectra groupings were associated with inflammation or other diseases of the airways.
Our results suggest that FTIR applied to sputum might have high sensitivity and specificity in diagnosing lung cancer with potential as a non-invasive, cost-effective and high-throughput method for screening.
ClinicalTrials.gov: NCT00899262.

Download full-text


Available from: Luis Mur,
  • Source
    • "Subtle differences in cell spectra have been used to distinguish cells in different stages in the cell cycle (Boydston-White et al. 2005), apoptotic cells (Liu et al. 2001) or cell lines (P.U. Otero et al. 2013, Verdonck et al. 2013), to identify cancer cells (Lewis et al. 2010), and to predict the aggressiveness of cancer cells (Gaigneaux et al. 2004). Several studies have shown a relationship between the mode of action of chemotherapy drugs and changes in FTIR spectra of dried cells (Berger et al. 2010, Derenne et al. 2011, Draux et al. 2009), as well as differences in FTIR spectra of drug-resistant and drug-sensitive cells (Rutter et al. 2014, Zendehdel et al. 2012, Zwielly et al. 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The study of the response of cancer cells to chemotherapy drugs is of high importance due to the specificity of some drugs to certain types of cancer and the resistance of some specific cancer types to chemotherapy drugs. Our aim was to develop and apply the label-free and non-destructive FTIR method to determine the sensitivity of three different cancer cells to a common anti-cancer drug doxorubicin at different concentrations and to demonstrate that information about the mechanism of resistance to the chemotherapy drug can be extracted from spectral data. HeLa, PC3 and Caco-2 cells were seeded and grown on an attenuated total reflection (ATR) crystal, doxorubicin was applied at the clinically significant concentration of 0.1-20 μM, and spectra of the cells were collected hourly over 20 hours. Analysis of the amide bands was correlated with cell viability, which had been cross validated with MTT assays, allowing to determine that the three cell lines had significantly different resistance to doxorubicin. The difference spectra and principal component analysis (PCA) highlighted the subtle chemical changes in the living cells under treatment. Spectral regions assigned to nucleic acids (mainly 1085 cm(-1)) and carbohydrates (mainly 1024 cm(-1)) showed changes that could be related to the mode of action of the drug and the mechanism of resistance of the cell lines to doxorubicin. This is a cost-effective method that does not require bioassay reagents but allows label-free, non-destructive and in situ analysis of chemical changes in live cells, using standard FTIR equipment adapted to ATR measurements. Copyright © 2015. Published by Elsevier B.V.
    Biochimica et Biophysica Acta 07/2015; 1853(10 Pt A). DOI:10.1016/j.bbamcr.2015.07.018 · 4.66 Impact Factor
  • Source
    • "Survival time for lung cancer is poor, with over 90% of patients dying within five years of diagnosis, primarily due to detection at a late stage. The main objective of some research projects was to evaluate FT-IR spectroscopy as a highthroughput and cost-effective method for identifying biochemical changes in sputum as biomarkers for detection of lung cancer (Lewis et al., 2010). A panel of 92 infrared wavenumbers had absorbances significantly different between cancer and normal sputum spectra and were associated with putative changes in protein, nucleic acid, and glycogen levels in tumors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This review provides a brief background to the application of infrared spectroscopy, including Fourier transform-infrared spectroscopy, in biological fluids. It is not meant to be complete or exhaustive but to provide the reader with sufficient background for selected applications in cancer diagnostics. Fourier transform-infrared spectroscopy (FT-IR) is a fast and nondestructive analytical method. The infrared spectrum of a mixture serves as the basis to quantitate its constituents, and a number of common clinical chemistry tests have proven to be feasible using this approach. This review focuses on biomedical FT-IR applications, published in the period 2009–2013, used for early detection of cancer through qualitative and quantitative analysis.
    Critical Reviews in Analytical Chemistry 04/2015; 45(2). DOI:10.1080/10408347.2014.904733 · 1.62 Impact Factor
  • Source
    • "The detection of cancer in early stage of its progression requires a large-scale screening. In lung detection, targets are smoking people, with previous history of cancer, and with COPD (Lewis et al., 2010). A screening program is required to be sensitive, but should also not be expensive, and should entail a non-invasive sample acquisition. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lung cancer is the leading cause of cancer-related deaths over the world, characterized by a very high mortality rate. Molecular technique development tries to focus on early detection of cancers by studying molecular alterations that characterize cancer cells. Worldwide lung cancer research has focused on an ever-increasing number of molecular elements of carcinogenesis at genetic, epigenetic and protein levels. The non-invasiveness is the characteristic that all clinical trials on cancer detection should have. Abnormal chest imaging and/or non-specific symptoms are initial signals of lung cancer that appear in an advanced stage of disease. This fact represents the cause of the low 5-year survival rate: over 90% of patients dying within five years of diagnosis. Since smokers have higher quantity of sputum containing exfoliated cells from the bronchial tree, and the sputum represents the most easily accessible biological fluid and its collection is non-invasive, analysis of this sample represents a good area of research in early lung cancer diagnosis. Continued cigarette smoking is the cause of chronic obstructive pulmonary disease (COPD), with an estimated attributable risk factor exceeding 80% in smoking affected individuals. Lung cancer is found in 40% - 70% of patients with COPD, particularly in severe disease, and it is a common cause of death in these patients. A large prospective trial of almost half a million non-smokers showed as lung cancer is also common in patients with COPD who have never smoked. This review describes issues related to early lung cancer screening using non-invasive methods. J. Cell. Physiol. © 2012 Wiley Periodicals, Inc.
    Journal of Cellular Physiology 05/2013; 228(5). DOI:10.1002/jcp.24263 · 3.84 Impact Factor
Show more